Evidence map›Paper›PMID 37701731›Full record

ArticlemedRxiv : the preprint server for health sciences2023

Psilocybin desynchronizes brain networks.

Joshua S Siegel, Subha Subramanian, Demetrius Perry, Benjamin Kay, Evan Gordon, Timothy Laumann, Rick Reneau, Caterina Gratton, Christine Horan, Nicholas Metcalf and 11 more

2 registry-linked trialsOpen access · greenAbstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07063862 phase3recruitingnot on this mapstarted 2026, after this paper: background citation

PSilocybin Microdose for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL): A Multi-site Phase 3 Double-blind, Placebo-controlled, Parallel-arm Clinical Trial

TypeinterventionalSponsorBruyère Health Research Institute.Ran2026 to 2027Enrolled120ConditionsPsychological DistressArmsPsilocybin, Placebo
NCT07169747 phase2recruitingnot on this mapstarted 2026, after this paper: background citation

The Therapeutic Potential of Psilocybin in Anorexia Nervosa in Young Adults

TypeinterventionalSponsorRegion SkaneRan2026 to 2027Enrolled40ConditionsAnorexia NervosaArmsPsilocybin
3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 14 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors at 2 institutions in 2 countries.

Joshua S Siegel
Subha Subramanian
Demetrius Perry
Benjamin Kay
Evan Gordon
Timothy Laumann
Rick Reneau
Caterina Gratton
Christine Horan
Nicholas Metcalf
Ravi Chacko
Julie Schweiger
Dean Wong
David Bender
Jonah Padawer-Curry
Charles Raison
Marcus Raichle
Eric J Lenze
Abraham Z Snyder
Nico U F Dosenbach
Ginger Nicol
Hadassah Medical Center · ILUniversity of Wisconsin–Madison · US

Funding

WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCESUL1TR002345 · NCATS · WASHINGTON UNIVERSITY · PI William G. Powderly · 2017 to 2026
$97.8M
BIOMEDICAL RESEARCH TRAINING IN DRUG ABUSET32DA007261 · NIDA · WASHINGTON UNIVERSITY · PI ARPANA AGRAWAL, Jose A Moron-Concepcion · 1991 to 2026
$8.8M
Sources and Functional Consequences of Individual Differences in Human Functional Brain Networks Related to Controlled BehaviorR01MH118370 · NIMH · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI GRATTON, CATERINA · 2019 to 2023
$3.4M
Precision-Mapping Functional Connectivity in Parkinson's DiseaseR01NS124738 · NINDS · WASHINGTON UNIVERSITY · PI MEGHAN C CAMPBELL, Caterina Gratton · 2023 to 2026
$2.4M
Washington University Psychiatry Residency Research Education ProgramR25MH112473 · NIMH · WASHINGTON UNIVERSITY · PI NURI B FARBER, Timothy Eric Spiegel · 2018 to 2026
$1.6M
Concussion and Attention-Deficit/Hyperactivity Disorder: Investigating the relationship between cognitive outcome, prescription stimulants, and functional MRI biomarkers in the ABCD study.K23NS123345 · NINDS · WASHINGTON UNIVERSITY · PI Benjamin Paul Kay · 2022 to 2026
$948k
NCATS NIH HHS UL1 TR002345NIDA NIH HHS T32 DA007261NIMH NIH HHS R01 MH118370NIMH NIH HHS R25 MH112473NINDS NIH HHS K23 NS123345NINDS NIH HHS R01 NS124738
6 · The paper itself

Abstract

1The relationship between the acute effects of psychedelics and their persisting neurobiological and psychological effects is poorly understood. Here, we tracked brain changes with longitudinal precision functional mapping in healthy adults before, during, and for up to 3 weeks after oral psilocybin and methylphenidate (17 MRI visits per participant) and again 6+ months later. Psilocybin disrupted connectivity across cortical networks and subcortical structures, producing more than 3-fold greater acute changes in functional networks than methylphenidate. These changes were driven by desynchronization of brain activity across spatial scales (area, network, whole brain). Psilocybin-driven desynchronization was observed across association cortex but strongest in the default mode network (DMN), which is connected to the anterior hippocampus and thought to create our sense of self. Performing a perceptual task reduced psilocybin-induced network changes, suggesting a neurobiological basis for

Identifiers

PMID37701731
PMCPMC10493007
OpenAlexW4386126549

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.